Adjunctive Therapies with LVADs

[1]  S. Westaby,et al.  Evidence for neoangiogenesis in the ischemic human heart after mechanical support and autologous bone marrow stem cell implantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  Isamu Mizote,et al.  Hemodynamic changes during left ventricular assist device-off test correlate with the degree of cardiac fibrosis and predict the outcome after device explantation , 2015, Journal of Artificial Organs.

[3]  Y. Puius,et al.  Role of Gallium SPECT-CT in the Diagnosis of Left Ventricular Assist Device Infections , 2015, ASAIO journal.

[4]  V. Dilsizian,et al.  FDG PET/CT imaging for LVAD associated infections. , 2014, JACC. Cardiovascular imaging.

[5]  Peter A. Altman,et al.  Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?: An Analysis From the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) Randomized Trial , 2014, Circulation research.

[6]  Peter A. Altman,et al.  Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?Novelty and Significance , 2014 .

[7]  S. Solomon,et al.  Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  Stuart Young,et al.  Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury. , 2014, Biomaterials.

[9]  Doris A Taylor,et al.  Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices , 2014, Circulation.

[10]  R. Hetzer,et al.  Contribution of ventricular assist devices to the recovery of failing hearts: a review and the Berlin Heart Center Experience , 2014, European journal of heart failure.

[11]  E. Birks,et al.  Treatment Strategies for Myocardial Recovery in Heart Failure , 2014, Current Treatment Options in Cardiovascular Medicine.

[12]  J. Marín-García,et al.  Myocardial regeneration of the failing heart , 2013, Heart Failure Reviews.

[13]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[14]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[15]  Y. Woo,et al.  Spatially Oriented, Temporally Sequential Smooth Muscle Cell-Endothelial Progenitor Cell Bi-Level Cell Sheet Neovascularizes Ischemic Myocardium , 2013, Circulation.

[16]  J. Burdick,et al.  Sustained Release of Engineered Stromal Cell–Derived Factor 1-&agr; From Injectable Hydrogels Effectively Recruits Endothelial Progenitor Cells and Preserves Ventricular Function After Myocardial Infarction , 2013, Circulation.

[17]  W. Koch,et al.  Heart Failure Gene Therapy: The Path to Clinical Practice , 2013, Circulation research.

[18]  E. Birks.  Molecular changes after left ventricular assist device support for heart failure. , 2013, Circulation research.

[19]  P. Serruys,et al.  Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac Function , 2013, Circulation research.

[20]  Dean Y. Li,et al.  Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. , 2013, Journal of the American College of Cardiology.

[21]  R. Hajjar,et al.  Gene Therapy for Heart Failure: Where Do We Stand? , 2013, Current Cardiology Reports.

[22]  L. Cooper,et al.  Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy. , 2012, Journal of cardiac failure.

[23]  R. Hetzer,et al.  Pre-Explant Stability of Unloading-Promoted Cardiac Improvement Predicts Outcome After Weaning From Ventricular Assist Devices , 2012, Circulation.

[24]  M. Yacoub,et al.  Mechanical unloading and cell therapy have a synergistic role in the recovery and regeneration of the failing heart. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  M. Guglin,et al.  Myocardial Recovery With Left Ventricular Assist Devices , 2012, Current Treatment Options in Cardiovascular Medicine.

[26]  Pranav Loyalka,et al.  Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation , 2012, Circulation.

[27]  M. Yacoub,et al.  Can Bridge to Recovery Help to Reveal the Secrets of the Failing Heart? , 2012, Current Cardiology Reports.

[28]  S. Westaby,et al.  Stem cells transplantation combined with long-term mechanical circulatory support enhances myocardial viability in end-stage ischemic cardiomyopathy. , 2012, International journal of cardiology.

[29]  D. Kass,et al.  Reverse remodeling in heart failure—mechanisms and therapeutic opportunities , 2012, Nature Reviews Cardiology.

[30]  Teruo Okano,et al.  Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case , 2012, Surgery Today.

[31]  J. Hare,et al.  Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.

[32]  H. Izutani,et al.  Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy , 2011, Surgery Today.

[33]  E. Lara-Pezzi,et al.  Reverse Remodelling and Recovery from Heart Failure Are Associated with Complex Patterns of Gene Expression , 2011, Journal of cardiovascular translational research.

[34]  Yoshiaki Kawase,et al.  Rescuing the failing heart by targeted gene transfer. , 2011, Journal of the American College of Cardiology.

[35]  M. Slaughter,et al.  Clinical, molecular, and genomic changes in response to a left ventricular assist device. , 2011, Journal of the American College of Cardiology.

[36]  Magdi H. Yacoub,et al.  Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study , 2011, Circulation.

[37]  S. Westaby,et al.  Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion , 2011, Journal of Translational Medicine.

[38]  P. Sanders,et al.  Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy. , 2010, JACC. Cardiovascular interventions.

[39]  E. Birks.  Myocardial Recovery in Patients with Chronic Heart Failure: Is It Real? , 2010, Journal of cardiac surgery.

[40]  N. Smedira,et al.  Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart. , 2010, The Journal of Heart and Lung Transplantation.

[41]  A. Arthur,et al.  Enrichment for STRO‐1 expression enhances the cardiovascular paracrine activity of human bone marrow‐derived mesenchymal cell populations , 2010, Journal of Cellular Physiology.

[42]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[43]  Eun Bo Shim,et al.  Computational analysis of the effect of the type of LVAD flow on coronary perfusion and ventricular afterload , 2009, The Journal of Physiological Sciences.

[44]  H. Iida,et al.  Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: Report of a case , 2009, Surgery Today.

[45]  R. Hetzer,et al.  Prediction of Cardiac Stability After Weaning From Left Ventricular Assist Devices in Patients With Idiopathic Dilated Cardiomyopathy , 2008, Circulation.

[46]  M. Yacoub,et al.  Prolonged mechanical unloading reduces myofilament sensitivity to calcium and sarcoplasmic reticulum calcium uptake leading to contractile dysfunction. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[47]  Karl E Nelson,et al.  Improving outcomes with long-term "destination" therapy using left ventricular assist devices. , 2008, The Journal of thoracic and cardiovascular surgery.

[48]  R. Hetzer,et al.  Intramyocardial Delivery of Bone Marrow Mononuclear Cells and Mechanical Assist Device Implantation in Patients with End-Stage Cardiomyopathy , 2007, Cell transplantation.

[49]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[50]  O H Frazier,et al.  Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group , 2007, Circulation.

[51]  J. Kors,et al.  Prevalence and Prognostic Significance of Heart Failure Stages: Application of the American College of Cardiology/American Heart Association Heart Failure Staging Criteria in the Community , 2007, Circulation.

[52]  Jeroen J. Bax,et al.  Role of imaging in cardiac stem cell therapy. , 2007, Journal of the American College of Cardiology.

[53]  N. Komiyama,et al.  Cardiac resurrection after bone-marrow-derived mononuclear cell transplantation during left ventricular assist device support. , 2007, The Annals of thoracic surgery.

[54]  Magdi H Yacoub,et al.  Left ventricular assist device and drug therapy for the reversal of heart failure. , 2006, The New England journal of medicine.

[55]  F. Pagani,et al.  Improved mechanical reliability of the HeartMate XVE left ventricular assist system. , 2006, The Annals of thoracic surgery.

[56]  N. de Jonge,et al.  Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[57]  M. Slaughter,et al.  Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[58]  D. Burkhoff,et al.  Cardiomyopathic Etiology and SERCA2a Reverse Remodeling During Mechanical Support of the Failing Human Heart , 2006, Anesthesia and analgesia.

[59]  B. Griffith,et al.  Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic Cardiomyopathy: Four-Year Follow-Up , 2005, Circulation.

[60]  F. Pagani,et al.  Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. , 2003, Journal of the American College of Cardiology.

[61]  Robert L Kormos,et al.  Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[62]  K. Wierzbicki,et al.  Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device. , 2002, The Journal of thoracic and cardiovascular surgery.

[63]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[64]  N. Smedira,et al.  Mechanical Unloading Restores &bgr;-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart , 2001, Circulation.

[65]  M Flannery,et al.  Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. , 1998, Circulation.

[66]  C. Selzman,et al.  Bridge to removal: a paradigm shift for left ventricular assist device therapy. , 2015, The Annals of thoracic surgery.

[67]  M. Yacoub,et al.  Bridge to recovery and weaning protocols. , 2014, Heart failure clinics.

[68]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[69]  M. Loebe,et al.  Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. , 2005, The Journal of surgical research.